REPONEX PHARMACEUTICALS AS has a total of 11 patent applications. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and medical technology are ARAFARMA GROUP S A, GP PHARM SA and AZANTA DANMARK AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Uttenthal Lars Otto | 11 |
#2 | Heslet Lars | 6 |
#3 | Bjørn Torsten | 4 |
#4 | Lindblad Lasse | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020221652A1 | Composition for the intraperitoneal treatment of secondary bacterial peritonitis with reduction of complications | |
WO2020188019A1 | Targeting biological agents to mucosal defects of the gastrointestinal tract | |
EP3740286A1 | Compositions for eliminating bacterial promotors of colorectal cancer by intraluminal application | |
US2017196937A1 | Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease |